PhD Monitor
/Detail
Biomedical and Disease Mechanisms● Open⏰ 12 days leftPreview

PhD Thesis in Large-Scale Proteomics and Structural Mass Spectrometry

Develop next-generation inhibitors targeting proteasome subtypes for autoimmune and cancer therapies.

Best for:Best for molecular biologists, structural biochemists, or proteomics specialists with experience in mass spectrometry and inhibitor design.

Institut de Pharmacologie et Biologie Structurale (IPBS) · Toulouse, France · R1 · First-stage researcher
More professors at Institut de Pharmacologie et Biologie Structurale (IPBS)
Proteasome inhibitor developmentAutoimmune disease mechanismsCancer biologyStructural mass spectrometryProteomicsDrug discovery
Deadline
Until filled
rolling
Funding
Stipend
Not specified (funded by ANR Proteasom-inhib project)
Start date
flexible (within 2024)
Full-time
Location
Toulouse
France

Overview

This PhD position at the Institut de Pharmacologie et Biologie Structurale (IPBS) focuses on advancing third-generation proteasome inhibitors to selectively target proteasome subtypes associated with PA28 activators. The project aims to reduce toxicity linked to current treatments for autoimmune diseases and cancer by developing highly specific inhibitors for complexes like i20S-PA28αβ and c20S-PA28γ. The work combines structural mass spectrometry, proteomics, and cell-based assays to evaluate inhibitor efficacy, specificity, and toxicity. The successful candidate will contribute to groundbreaking research with potential clinical applications in autoimmune diseases, inflammatory conditions, and cancer treatment.

Proteasome inhibitorsAutoimmune diseasesCancer therapyMass spectrometryProteomicsPA28 activatorsStructural biologyDrug selectivity

What you'll do

  • Develop and evaluate third-generation proteasome inhibitors targeting i20S-PA28αβ and c20S-PA28γ complexes.
  • Conduct in vitro and in cellulo assays to assess inhibitor efficacy, specificity, and toxicity.
  • Perform large-scale proteomics and structural mass spectrometry to analyze off-target effects and binding specificity.
  • Identify and characterize peptides that reflect inhibitor binding to target and off-target proteins.
  • Study the mechanism of action of inhibitors, including effects on proteasome disassembly and stoichiometry.
  • Publish findings in high-impact scientific journals and present results at international conferences.
  • Collaborate with interdisciplinary teams to integrate findings into broader drug discovery pipelines.

Requirements

Degree required: Master's degree (MSc) in Molecular Biology, Biochemistry, Structural Biology, Pharmacology, or a related field.

Degree offered: PhD

Language: English; proficiency required for scientific communication and collaboration.

Instruction: French and English

Required skills
  • Experience in proteomics and mass spectrometry techniques.
  • Proficient in molecular biology techniques (e.g., cloning, protein expression, purification).
  • Familiarity with cell culture and biochemical assays.
  • Strong background in structural biology or inhibitor design.
  • Proficiency in data analysis and bioinformatics tools for proteomics.
  • Ability to work independently and collaboratively in a research lab.
Nice to have
Experience with computational modeling or drug discovery pipelines.Knowledge of autoimmune disease mechanisms or cancer biology.Familiarity with advanced imaging techniques (e.g., cryo-EM, NMR).Publication record in top-tier journals.
Eligibility
  • No specific nationality restrictions.
  • Applicants must hold a Master's degree in a relevant field.
  • No age restrictions mentioned.

Funding & terms

Type
Stipend
Amount
Not specified (funded by ANR Proteasom-inhib project)
Duration
3 years
Programme
ANR Proteasom-inhib
Agence Nationale de la Recherche (ANR)

How to apply

Deadline: open_until_filled · open until filled

Interested candidates should submit a detailed CV, a cover letter outlining their research experience and motivation, and a research proposal (max 2 pages) to the contact email. Two letters of recommendation are also required.

Documents required
  • CV
  • Cover letter
  • Research proposal (max 2 pages)
  • Two letters of recommendation
✉Apply by email

Contact

First Last· PhD Supervisor

[redacted]

FL
Prof.
First Last
Institut de Pharmacologie et Biologie Structurale
Lab
Proteasome and Autoimmune Disease Research Group
Institut de Pharmacologie et Biologie Structurale (IPBS)
ANR Proteasom-inhibFrance
See the full position

Create a free profile to unlock your personal match score, the full requirements, funding details and how to apply — in English or Persian.

No card · 10 free AI match scores
Ready to apply?
12 days until the deadline — open this position on its website.